Companies race to swallow poison pills to thwart hostile bids

‘As stock prices dropped precipitously in March, many companies were quick to either put poison pills in place or put them on the proverbial “shelf,” says Frank Aquila, global head of M&A at international law firm Sullivan & Cromwell